The U.S. ADHD Therapeutics Market size is USD 5.47 Billion in 2025 and is expected to reach USD 6.68 Billion by 2035, growing at a CAGR of 1.56% over 2026-2035. Some of the key factors propelling the ...
The high cost of undiagnosed and untreated ADHD: Unequal mental‑health access and the care economy
Attention deficit hyperactivity disorder (ADHD) is a common neurodevelopmental disorder that can persist from childhood into older adulthood. It impacts individuals from all ethnic groups and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results